Literature DB >> 30507913

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles.

John W Hickey1, Jonathan P Schneck2.   

Abstract

We have developed a tool to both enrich and expand antigen-specific T cells. This can be helpful in cases such as to A) detect the existence of antigen-specific T cells, B) probe the dynamics of antigen-specific responses, C) understand how antigen-specific responses affect disease state such as autoimmunity, D) demystify heterogeneous responses for antigen-specific T cells, or E) utilize antigen-specific cells for therapy. The tool is based on a magnetic particle that we conjugate antigen-specific and T cell co-stimulatory signals, and that we term as artificial antigen presenting cells (aAPCs). Consequently, since the technology is simple to produce, it can easily be adopted by other laboratories; thus, our purpose here is to describe in detail the fabrication and subsequent use of the aAPCs. We explain how to attach antigen-specific and co-stimulatory signals to the aAPCs, how to utilize them to enrich for antigen-specific T cells, and how to expand antigen-specific T cells. Furthermore, we will highlight engineering design considerations based on experimental and biological information of our experience with characterizing antigen-specific T cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30507913      PMCID: PMC6724533          DOI: 10.3791/58640

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  18 in total

1.  Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

Authors:  Mahesh Yadav; Suchit Jhunjhunwala; Qui T Phung; Patrick Lupardus; Joshua Tanguay; Stephanie Bumbaca; Christian Franci; Tommy K Cheung; Jens Fritsche; Toni Weinschenk; Zora Modrusan; Ira Mellman; Jennie R Lill; Lélia Delamarre
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

2.  Exploiting the mutanome for tumor vaccination.

Authors:  John C Castle; Sebastian Kreiter; Jan Diekmann; Martin Löwer; Niels van de Roemer; Jos de Graaf; Abderraouf Selmi; Mustafa Diken; Sebastian Boegel; Claudia Paret; Michael Koslowski; Andreas N Kuhn; Cedrik M Britten; Christoph Huber; Ozlem Türeci; Ugur Sahin
Journal:  Cancer Res       Date:  2012-01-11       Impact factor: 12.701

3.  Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.

Authors:  M Oelke; U Moehrle; J L Chen; D Behringer; V Cerundolo; A Lindemann; A Mackensen
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

Review 4.  The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude.

Authors:  Marc K Jenkins; James J Moon
Journal:  J Immunol       Date:  2012-05-01       Impact factor: 5.422

5.  Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.

Authors:  Despina Rudolf; Tobias Silberzahn; Steffen Walter; Dominik Maurer; Johanna Engelhard; Dorothee Wernet; Hans-Jörg Bühring; Gundram Jung; Byoung S Kwon; Hans-Georg Rammensee; Stefan Stevanović
Journal:  Cancer Immunol Immunother       Date:  2007-07-27       Impact factor: 6.968

6.  In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.

Authors:  William Y Ho; Hieu N Nguyen; Matthias Wolfl; Juergen Kuball; Philip D Greenberg
Journal:  J Immunol Methods       Date:  2006-01-26       Impact factor: 2.303

Review 7.  Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells.

Authors:  Evan W Newell; Mark M Davis
Journal:  Nat Biotechnol       Date:  2014-01-19       Impact factor: 54.908

8.  Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.

Authors:  Gabrielle A Rizzuto; Taha Merghoub; Daniel Hirschhorn-Cymerman; Cailian Liu; Alexander M Lesokhin; Diana Sahawneh; Hong Zhong; Katherine S Panageas; Miguel-Angel Perales; Grégoire Altan-Bonnet; Jedd D Wolchok; Alan N Houghton
Journal:  J Exp Med       Date:  2009-03-30       Impact factor: 14.307

Review 9.  Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges.

Authors:  Pramod K Srivastava; Fei Duan
Journal:  Cancer Immunol Immunother       Date:  2013-04-19       Impact factor: 6.968

10.  Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity.

Authors:  Fei Duan; Jorge Duitama; Sahar Al Seesi; Cory M Ayres; Steven A Corcelli; Arpita P Pawashe; Tatiana Blanchard; David McMahon; John Sidney; Alessandro Sette; Brian M Baker; Ion I Mandoiu; Pramod K Srivastava
Journal:  J Exp Med       Date:  2014-09-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.